Search - tctmd.com

Displaying 281 - 300 of 370

Sort: Relevancy | Date

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

Transseptal Wet Models

Presenter: Mayra Guerrero

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Todd Neale

April 04, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Presentation TCT 2016

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? Yes, in Most Patients, to Improve Prognosis and Reduce Costs!

Presenter: Adrian P. Banning, Nick Curzen, Keith G. Oldroyd

November 01, 2016

Presentation TCT 2016

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? No, in the Middle of the Night and With Complex Anatomy ... Are You Kidding?!

Presenter: Adrian P. Banning, Nick Curzen, Herbert D. Aronow

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing!

Presenter: Adrian P. Banning, Nick Curzen, Samir B. Pancholy

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Presenter: Adrian P. Banning, Nick Curzen, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

2016 CTO Revascularization Update

Presenter: Sripal Bangalore, George D. Dangas, Khaldoon Alaswad

November 01, 2016

Presentation TCT 2016

2016 STEMI PCI Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

Announcing the NIH-sponsored HYBRID Revascularization Trial

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

2016 DAPT Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla

November 01, 2016

Presentation TCT 2016

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux

November 01, 2016

Advertisement

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Transseptal Wet Models

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? Yes, in Most Patients, to Improve Prognosis and Reduce Costs!

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? No, in the Middle of the Night and With Complex Anatomy ... Are You Kidding?!

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing!

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

2016 CTO Revascularization Update

2016 STEMI PCI Update: Evidence and Guidelines

Announcing the NIH-sponsored HYBRID Revascularization Trial

2016 DAPT Update: Evidence and Guidelines

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content